IL274202A - Anti-glyco-muc1 antibodies and their uses - Google Patents

Anti-glyco-muc1 antibodies and their uses

Info

Publication number
IL274202A
IL274202A IL274202A IL27420220A IL274202A IL 274202 A IL274202 A IL 274202A IL 274202 A IL274202 A IL 274202A IL 27420220 A IL27420220 A IL 27420220A IL 274202 A IL274202 A IL 274202A
Authority
IL
Israel
Prior art keywords
glyco
muc1 antibodies
muc1
antibodies
Prior art date
Application number
IL274202A
Other languages
Hebrew (he)
Original Assignee
Go Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Go Therapeutics Inc filed Critical Go Therapeutics Inc
Publication of IL274202A publication Critical patent/IL274202A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3076—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
    • C07K16/3092—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties against tumour-associated mucins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4725—Mucins, e.g. human intestinal mucin
IL274202A 2017-10-24 2020-04-23 Anti-glyco-muc1 antibodies and their uses IL274202A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2017/058036 WO2019083506A1 (en) 2017-10-24 2017-10-24 Anti-glyco-muc1 antibodies and their uses

Publications (1)

Publication Number Publication Date
IL274202A true IL274202A (en) 2020-06-30

Family

ID=66247577

Family Applications (1)

Application Number Title Priority Date Filing Date
IL274202A IL274202A (en) 2017-10-24 2020-04-23 Anti-glyco-muc1 antibodies and their uses

Country Status (10)

Country Link
EP (1) EP3700936A4 (en)
JP (2) JP7358367B2 (en)
KR (2) KR102608763B1 (en)
CN (1) CN111479828A (en)
AU (1) AU2017436815A1 (en)
BR (1) BR112020008001A2 (en)
CA (1) CA3078812A1 (en)
IL (1) IL274202A (en)
MX (1) MX2020004220A (en)
WO (1) WO2019083506A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114796498A (en) * 2022-01-27 2022-07-29 中国农业大学 Application of substance for inhibiting MUC1 glycosylation modification in improving sensitivity of breast cancer cells to anti-breast cancer drugs

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1268800A2 (en) * 2000-03-30 2003-01-02 Dyax Corporation Mucin-1 specific binding members and methods of use thereof
DE10303664A1 (en) * 2003-01-23 2004-08-12 Nemod Immuntherapie Ag Detection molecules for the treatment and detection of tumors
EP2014302A1 (en) * 2007-07-12 2009-01-14 Institut Curie An antibody specific for the Tn antigen for the treatment of cancer
AU2008332296A1 (en) * 2007-12-05 2009-06-11 Kyowa Hakko Kirin Co., Ltd. Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
JP5773352B2 (en) * 2008-10-28 2015-09-02 塩野義製薬株式会社 Anti-MUC1 antibody
EP2281844A1 (en) * 2009-07-31 2011-02-09 Glycotope GmbH MUC 1 antibodies
US10208125B2 (en) * 2013-07-15 2019-02-19 University of Pittsburgh—of the Commonwealth System of Higher Education Anti-mucin 1 binding agents and uses thereof
AU2015254257B2 (en) * 2014-04-28 2021-02-25 Medicinal Chemistry Pharmaceuticals, Co., Ltd. Anti-MUC1 antibody or antigen-binding fragment of same, and use thereof

Also Published As

Publication number Publication date
EP3700936A1 (en) 2020-09-02
AU2017436815A1 (en) 2020-04-23
MX2020004220A (en) 2020-10-05
KR20230165874A (en) 2023-12-05
CA3078812A1 (en) 2019-05-02
KR102608763B1 (en) 2023-11-30
CN111479828A (en) 2020-07-31
JP7358367B2 (en) 2023-10-10
WO2019083506A1 (en) 2019-05-02
EP3700936A4 (en) 2021-05-26
JP2021510307A (en) 2021-04-22
JP2024001073A (en) 2024-01-09
BR112020008001A2 (en) 2020-10-20
KR20200067885A (en) 2020-06-12

Similar Documents

Publication Publication Date Title
IL290842A (en) Anti-cd73 antibodies and uses thereof
ZA202102905B (en) Anti-galectin-9 antibodies and uses thereof
ZA202101318B (en) Anti-phf-tau antibodies and uses thereof
IL272218A (en) Anti-sirp-alpha antibodies and related methods
ZA202105676B (en) Anti-trem2 antibodies and related methods
IL268734A (en) Anti-lag-3 antibodies and uses thereof
IL266738A (en) Novel antibodies and uses thereof
IL271477A (en) Anti-cd166 antibodies and uses thereof
IL262095A (en) Anti-pacap antibodies and uses thereof
IL269134A (en) Anti-par2 antibodies and uses thereof
ZA201901935B (en) Anti-il-33 antibodies and uses thereof
IL272476A (en) Anti-apelin antibodies and uses thereof
IL273157A (en) Axl-specific antibodies and uses thereof
IL266049A (en) Anti-o1 antibodies and uses thereof
IL271398A (en) Anti-l1-cam antibodies and uses thereof
IL266082A (en) Anti-chikv antibodies and uses thereof
IL264417A (en) Anti-o2 antibodies and uses thereof
GB201712032D0 (en) Antibodies and uses thereof
IL274202A (en) Anti-glyco-muc1 antibodies and their uses
GB201820334D0 (en) Antibodies and their uses